Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SZSE: 002317)
Health Care · Pharmaceuticals · CN
CN¥24.03
+2.91% today · +41.7% 1Y
Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SZSE: 002317) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.04B and employs 1,757 people.
Over the last twelve months the share price has gained 41.7%, trading between 16.20 and 34.27.
Tweenvest scores Guangdong Zhongsheng Pharmaceutical Co., Ltd. across four factors: quality 76/100, value 14/100, growth 28/100, dividend 52/100. Its strongest factor is quality.
002317 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.04B
- Revenue (TTM)
- $327.32M
- P/E
- 100.94
- EPS
- 0.24
- Dividend yield
- 0.83%
- Beta (5Y)
- 0.63
- 52-week high
- CN¥34.27
- 52-week low
- CN¥16.20
- Avg volume (3M)
- —
- Shares outstanding
- 849.93M
- Employees
- 1,757
- Next earnings
- —
About Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
- ISIN
- CNE100000HW4
- Founded
- 2001
- Listed since
- Dec 11, 2009
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hybio Pharmaceutical Co., Ltd.SZSE: 300199 | $3.15B | CN¥23.92 | +2.66% |
| Hebei Changshan Biochemical Pharmaceutical Co., Ltd.SZSE: 300255 | $3.14B | CN¥22.94 | -0.74% |
| Tasly Pharmaceutical Group Co., LtdSHSE: 600535 | $3.12B | CN¥14.00 | +2.34% |
| Sunshine Lake Pharma Co., Ltd.SEHK: 6887 | $3.09B | HK$42.12 | +6.36% |
| Jilin Aodong Pharmaceutical Group Co., Ltd.SZSE: 000623 | $3.04B | CN¥17.41 | -0.40% |
| Chengdu Kanghong Pharmaceutical Group Co., LtdSZSE: 002773 | $2.99B | CN¥21.80 | +6.76% |
| Enliven Therapeutics, Inc.NasdaqGS: ELVN | $2.98B | $40.63 | -1.76% |
| Virbac SAENXTPA: VIRP | $2.96B | €315.50 | -0.79% |
Figures last refreshed Oct 4, 2026.